Loading clinical trials...
Loading clinical trials...
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Conditions
Interventions
YM443
Locations
59
United States
Dr. Suresh Karne
Huntsville, Alabama, United States
James Thrasher, MD
Little Rock, Arkansas, United States
Dr. Dennis Riff
Anaheim, California, United States
Dr. Peter Winkle
Cypress, California, United States
Dr. Ramin Farsad
Encinitas, California, United States
Dr. Prahalad Jajodia
Fresno, California, United States
Start Date
March 10, 2004
Primary Completion Date
March 11, 2006
Completion Date
March 11, 2006
Last Updated
January 10, 2018
NCT07169851
NCT07403370
NCT06326983
NCT07274215
NCT07271147
NCT04150614
Lead Sponsor
Astellas Pharma Inc
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions